1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Editorial: intravenous to subcutaneous vedolizumab—switch without glitch! Authors' reply
2022) In Alimentary Pharmacology and Therapeutics(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Letter: to switch or not to switch, that is the question—author's reply
(
- Contribution to journal › Letter
- 2013
-
Mark
Letter: successful mercaptopurine therapy after azathioprine-related pancreatitis in patients with IBD - authors' reply.
(
- Contribution to journal › Letter
- 2012
-
Mark
Fatigue in out-patients with inflammatory bowel disease is common and multifactorial.
(
- Contribution to journal › Article
- 2011
-
Mark
Hospitalisation of and mortality from bleeding peptic ulcer in Sweden: a nationwide time-trend analysis.
(
- Contribution to journal › Article
- 2010
-
Mark
Mortality from peptic ulcer bleeding: the impact of comorbidity and the use of drugs that promote bleeding.
(
- Contribution to journal › Article
- 2009
-
Mark
Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease.
(
- Contribution to journal › Article
-
Mark
Bleeding peptic ulcer - time trends in incidence, treatment and mortality in Sweden.
(
- Contribution to journal › Article